AGP Picks
View all

Tech Daily Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Utah.

Press releases published on July 21, 2026

Techcyte Marks 11 Million AI-Assisted Scans Across Its Global Platform
ClientTether and GlassHouse Connect Digital Door Knocking With Automated Customer Follow-Up for Home Service Franchises
New study finds GLP-1 receptor agonists associated with lower risk of alcohol-related hospitalization among adults with alcohol use disorder
SWOGE Announces Community-Driven Meme Coin Expansion on Solana
U.S. House Unanimously Passes DeOndra Dixon INCLUDE Project Act – A Historic Victory for Down Syndrome Research
Stride Announces Date for Fourth Quarter Fiscal Year 2026 Earnings Call
TLX591-Tx ProstACT SELECT Study Published in Cancers Journal
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
KPA Expands Automotive EHS Solutions to Help Businesses Maintain Compliance
Acrivon to Highlight the Power of its AP3 Platform for Streamlined, Pathway-Based Drug Discovery and Development with Oral and Poster Presentations at AACR D3 Conference
BlackLine Announces Date for Second Quarter 2026 Earnings Release and Conference Call
BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026
GoHealth Successfully Completes Financial Restructuring and Emerges Well Positioned for Future Success
Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Publication in Cancer Research Details Atebimetinib’s Broad, Durable Preclinical Activity and Favorable Tolerability Across RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition
Inspired to Report Second Quarter 2026 Results and Hold Conference Call on August 6th
Inkoop van eigen aandelen
Acquisition of Own Shares
Nurix Therapeutics Announces HSR Clearance of Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Daily Utah

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.